175 related articles for article (PubMed ID: 8114845)
1. Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis.
Hirsh J
N Engl J Med; 1994 Mar; 330(12):862-3. PubMed ID: 8114845
[No Abstract] [Full Text] [Related]
2. Low-molecular-weight heparin vs. warfarin for prophylaxis against deep-vein thrombosis.
Lotke PA; Ecker ML
N Engl J Med; 1994 Mar; 330(12):863. PubMed ID: 8114846
[No Abstract] [Full Text] [Related]
3. Prophylaxis of postoperative deep vein thrombosis in general surgery: experiences with Fragmin.
Bergqvist D
Acta Chir Scand Suppl; 1988; 543():87-9. PubMed ID: 2847463
[No Abstract] [Full Text] [Related]
4. Cost-benefit analysis of prophylaxis against deep vein thrombosis in surgery.
Hauch O; Khattar SC; Jørgensen LN
Semin Thromb Hemost; 1991; 17 Suppl 3():280-3. PubMed ID: 1661436
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
[TBL] [Abstract][Full Text] [Related]
6. [Apropos of the assessment of "prophylaxis of deep vein thrombosis in orthopedic surgery"].
Boutin B
J Chir (Paris); 1994 May; 131(5):277-8. PubMed ID: 7989420
[No Abstract] [Full Text] [Related]
7. Subcutaneous low-molecular-weight heparin compared with continuous intravenous unfractionated heparin in the treatment of proximal deep vein thrombosis.
Simonneau G; Charbonnier B; Decousus H; Planchon B; Ninet J; Sie P; Silsiguen M; Combe S
Arch Intern Med; 1993 Jul; 153(13):1541-6. PubMed ID: 8391792
[TBL] [Abstract][Full Text] [Related]
8. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
[No Abstract] [Full Text] [Related]
9. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
Koch A; Bouges S; Ziegler S; Dinkel H; Daures JP; Victor N
Br J Surg; 1997 Jun; 84(6):750-9. PubMed ID: 9189079
[TBL] [Abstract][Full Text] [Related]
10. Low molecular weight heparin for the prevention of deep vein thrombosis following orthopedic surgery.
Lassen MR; Borris LC
Curr Opin Pulm Med; 1996 Jul; 2(4):300-4. PubMed ID: 9363156
[TBL] [Abstract][Full Text] [Related]
11. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
[TBL] [Abstract][Full Text] [Related]
12. Treatment of the patient with deep vein thrombosis.
Weismantel D
J Fam Pract; 2001 Mar; 50(3):249-56. PubMed ID: 11252215
[No Abstract] [Full Text] [Related]
13. Low molecular weight heparin: laboratory properties and clinical evaluation. A review.
Hirsh J; Levine MN
Eur J Surg Suppl; 1994; (571):9-22. PubMed ID: 7519092
[No Abstract] [Full Text] [Related]
14. [Deep venous thrombosis--treatment].
Fries R; Böhm M
Dtsch Med Wochenschr; 2003 May; 128(18):999-1002. PubMed ID: 12721879
[No Abstract] [Full Text] [Related]
15. Treatment of deep vein thrombosis (DVT) with low molecular weight heparins (LMWH).
Samama MM
Adv Exp Med Biol; 1992; 313():275-81. PubMed ID: 1332441
[No Abstract] [Full Text] [Related]
16. Prevention of thrombosis during pregnancy.
Vilela VS; de Jesús NR; Levy RA
Isr Med Assoc J; 2002 Oct; 4(10):794-7. PubMed ID: 12389343
[No Abstract] [Full Text] [Related]
17. [Topical administration of unfractionated and low molecular weight heparin for prevention of appositional thrombus formation].
Koppenhagen K; Häring R; Proksch W; Erdmann K; Leick M; Bundrock P; Franke J
Vasa Suppl; 1992; 35():99-100. PubMed ID: 1336219
[No Abstract] [Full Text] [Related]
18. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses.
Bergqvist D
Br J Surg; 1998 Jun; 85(6):872. PubMed ID: 9667723
[No Abstract] [Full Text] [Related]
19. Secondary prophylaxis with low molecular weight heparin: the dose?
Horne MK
Thromb Haemost; 2001 Oct; 86(4):1129. PubMed ID: 11686343
[No Abstract] [Full Text] [Related]
20. Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin.
Forbes CD
Br J Clin Pract; 1989 Nov; 43(11):396-400. PubMed ID: 2558702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
